User Posts: ahead intel
Artificial Blood Substitutes is an alternate technique for blood transfusion. Blood substitutes are expected to have an oxygen-carrying capacity similar ...
ahead intel
Plants are a significant source of crops for human consumption, raw materials for animal feed, plant-based chemicals for industrial use, and renewable ...
The rush to CRISPR Cas9 is due to the possibility of potential billions in the business of CRISPR technology. It is exemplified by the topical advent of ...
View the complete report here: CRISPR Cas9 Market Patent Landscape Report CRISPR Cas9 Market Report Infographics The global markets for CRISPR Cas9 Market ...
CRISPR Cas9 Genome editing market worth $5.3 billion by 2025 The report CRISPR Cas9 Genome editing market and Patent Landscape Report , by Applications ...
Artificial Blood Substitutes Market Report and Patent Landscape Analysis Artificial blood Substitute is an artificially developed substitute for red blood ...
View the complete report here: Artificial Blood Substitutes Market and Patent Landscape Report Share this Image On Your Site </p><br /> ...
Artificial Blood Substitutes market worth $5,204 million by 2022 The report Artificial Blood Substitutes Market – Patent landscape report, by source (human ...
Quantum Dots Market Report and Patent Landscape Analysis Existing and future market integration’s of Quantum Dots technology impacts a broad range of ...
Quantum Dots enabled product market is expected to reach $5.69 billion by 2022 endorsed by significant growth in patenting activity Global Quantum Dots ...
View the complete report here: Quantum Dots Global Market and Patent Landscape Report Share this Image On Your Site </p> <p><strong>Please ...
User Deals: ahead intel
- The global market for Li-ion battery has been recorded $37.40 billion in 2018 which is projected to become $105.92 billion in 2025 with the CAGR of 16.03 percent
- Toyota Group holds the most extensive patent portfolio in Li-ion battery technology with 3,840 IP assets
- The highest revenue is expected for the energy grid and storage industry to reach up to $XX billion in 2025 with the CAGR of XX percent
- The market for electric vehicles (EVs) is rising at a significant rate in China, North America, and Europe
- The global markets for Cannabis were estimated at $14.5 billion in 2018. It is expected to reach $107.67 billion by 2025 growing at a CAGR of 33.17 percent
- With a seven-year CAGR of 26.92 percent, the North America market is predicted to continue dominating the global markets
- Abbvie Inc holds the largest patent portfolio in cannabis technology with 216 IP assets
- The most researched product type is marijuana-infused products with 5659 patents
- The global market for laser technology in the year 2018 is recorded $12.95 billion which is projected to grow to $17.97 billion in 2025 with CAGR of 4.78 percent.
- Processing, instrumentation and printing application segment occupied 33 percent of North American market
- Mitsubishi Group holds the most extensive patent portfolio in LASER technology with 616 IP assets, within the past ~5 years
- Most of the R&D activity in laser technology is taking place in Japan with 8960 patents having Japan as the priority country
- QDs enabled product market is expected to reach $5.69 billion by 2022
- Samsung and LG are the pioneers in research and development (R&D). TCL group and BOE Technology Group are the new entrants
- The University of Shanghai is the most active player in R&D for QDs application in pharmaceutical industry and has filed 118 patents in this domain.
- One of the critical emerging geographies from technology innovation perspective is India which is showing trends of active patent fillings at a CAGR of 43 percent
- Global potential artificial blood substitutes market is expected to be valued at $5,204 million by 2022 and is expected to grow by a CAGR of 27.8 percent to assume a value of $17,775 million by 2027
- R&D interest in artificial blood products technologies has maintained at a constant pace with approximately 67 patents filed every year over the period from 1997 to 2016.
- Injuries segment will be the biggest contributor at $1,993 million to artificial blood substitutes market in 2022.
- One of the critical emerging geographies from technology innovation perspective is Korea which is showing trends of active patent fillings for the period 2011 to 2016.
- The global markets for CRISPR-Cas9 genome editing were estimated at $1.22 billion in 2017. It is expected to reach $5.3 billion by 2025 growing at a CAGR of 20.19 per cent.
- With the USFDA announcement of CRISPR-Cas9 edited crops being treated as non-GMOs, in 2025 the application segment is expected to grow by four times of its market size in 2017.
- Clinical therapy segment is the leading focus area of R&D with 482 patent applications.
- Massachusetts Institute of Technology (MIT) holds the largest patent portfolio in CRISPR-Cas9 technology with 103 IP assets.
